Viewing Study NCT05528666


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-07 @ 9:51 AM
Study NCT ID: NCT05528666
Status: COMPLETED
Last Update Posted: 2022-11-08
First Post: 2022-09-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Risk Perception in Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module